174 related articles for article (PubMed ID: 3110375)
1. Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.
Arnett CD; Fowler JS; MacGregor RR; Schlyer DJ; Wolf AP; Långström B; Halldin C
J Neurochem; 1987 Aug; 49(2):522-7. PubMed ID: 3110375
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic positron emission tomography studies: demonstration of a deuterium isotope effect in the monoamine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain.
Fowler JS; Wolf AP; MacGregor RR; Dewey SL; Logan J; Schlyer DJ; Langstrom B
J Neurochem; 1988 Nov; 51(5):1524-34. PubMed ID: 3139834
[TBL] [Abstract][Full Text] [Related]
3. Turnover of monoamine oxidase B (MAO-B) in pig brain by positron emission tomography using 11C-L-deprenyl.
Oreland L; Jossan SS; Hartvig P; Aquilonius SM; Långström B
J Neural Transm Suppl; 1990; 32():55-9. PubMed ID: 2128512
[TBL] [Abstract][Full Text] [Related]
4. Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography.
Lammertsma AA; Bench CJ; Price GW; Cremer JE; Luthra SK; Turton D; Wood ND; Frackowiak RS
J Cereb Blood Flow Metab; 1991 Jul; 11(4):545-56. PubMed ID: 1904879
[TBL] [Abstract][Full Text] [Related]
5. An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo.
Fowler JS; Volkow ND; Logan J; Pappas N; King P; MacGregor R; Shea C; Garza V; Gatley SJ
Life Sci; 1998; 63(2):PL19-23. PubMed ID: 9674950
[TBL] [Abstract][Full Text] [Related]
6. PET imaging of monoamine oxidase B in peripheral organs in humans.
Fowler JS; Logan J; Wang GJ; Volkow ND; Zhu W; Franceschi D; Pappas N; Ferrieri R; Shea C; Garza V; Xu Y; MacGregor RR; Schlyer D; Gatley SJ; Ding YS; Alexoff D
J Nucl Med; 2002 Oct; 43(10):1331-8. PubMed ID: 12368371
[TBL] [Abstract][Full Text] [Related]
7. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.
Fowler JS; MacGregor RR; Wolf AP; Arnett CD; Dewey SL; Schlyer D; Christman D; Logan J; Smith M; Sachs H
Science; 1987 Jan; 235(4787):481-5. PubMed ID: 3099392
[TBL] [Abstract][Full Text] [Related]
8. Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping.
Fowler JS; Wang GJ; Logan J; Xie S; Volkow ND; MacGregor RR; Schlyer DJ; Pappas N; Alexoff DL; Patlak C
J Nucl Med; 1995 Jul; 36(7):1255-62. PubMed ID: 7790952
[TBL] [Abstract][Full Text] [Related]
9. Selective, irreversible in vivo binding of [11C]clorgyline and [11C]-L-deprenyl in mice: potential for measurement of functional monoamine oxidase activity in brain using positron emission tomography.
MacGregor RR; Halldin C; Fowler JS; Wolf AP; Arnett CD; Langström B; Alexoff D
Biochem Pharmacol; 1985 Sep; 34(17):3207-10. PubMed ID: 3929788
[No Abstract] [Full Text] [Related]
10. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
Bench CJ; Price GW; Lammertsma AA; Cremer JC; Luthra SK; Turton D; Dolan RJ; Kettler R; Dingemanse J; Da Prada M
Eur J Clin Pharmacol; 1991; 40(2):169-73. PubMed ID: 1906004
[TBL] [Abstract][Full Text] [Related]
11. Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal.
Fowler JS; Volkow ND; Logan J; Wang GJ; MacGregor RR; Schyler D; Wolf AP; Pappas N; Alexoff D; Shea C
Synapse; 1994 Oct; 18(2):86-93. PubMed ID: 7839316
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.
Logan J; Fowler JS; Volkow ND; Wang GJ; MacGregor RR; Shea C
Nucl Med Biol; 2000 Jan; 27(1):43-9. PubMed ID: 10755644
[TBL] [Abstract][Full Text] [Related]
13. Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
Hirvonen J; Kailajärvi M; Haltia T; Koskimies S; Någren K; Virsu P; Oikonen V; Sipilä H; Ruokoniemi P; Virtanen K; Scheinin M; Rinne JO
Clin Pharmacol Ther; 2009 May; 85(5):506-12. PubMed ID: 19129751
[TBL] [Abstract][Full Text] [Related]
14. Radioactive N,N-dimethylphenylethylamine: a selective radiotracer for in vivo measurement of monoamine oxidase-B activity in the brain.
Inoue O; Tominaga T; Yamasaki T; Kinemuchi H
J Neurochem; 1985 Jan; 44(1):210-6. PubMed ID: 3917289
[TBL] [Abstract][Full Text] [Related]
15. Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.
Fowler JS; Logan J; Volkow ND; Shumay E; McCall-Perez F; Jayne M; Wang GJ; Alexoff DL; Apelskog-Torres K; Hubbard B; Carter P; King P; Fahn S; Gilmor M; Telang F; Shea C; Xu Y; Muench L
Neuropsychopharmacology; 2015 Feb; 40(3):650-7. PubMed ID: 25249059
[TBL] [Abstract][Full Text] [Related]
16. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
18. Recovery of MAO-B enzyme activity after (-)deprenyl (selegiline) pretreatment, measured in vivo.
Timár J
Acta Physiol Hung; 1989; 74(3-4):259-66. PubMed ID: 2517980
[TBL] [Abstract][Full Text] [Related]
19. The influence of metabolism on the MAO-B inhibitory potency of selegiline.
Haberle D; Szökõ E; Magyar K
Curr Med Chem; 2002 Jan; 9(1):47-51. PubMed ID: 11860347
[TBL] [Abstract][Full Text] [Related]
20. In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.
Freedman NM; Mishani E; Krausz Y; Weininger J; Lester H; Blaugrund E; Ehrlich D; Chisin R
J Nucl Med; 2005 Oct; 46(10):1618-24. PubMed ID: 16204711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
